Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.940
-0.120 (-2.96%)
At close: May 1, 2026, 4:00 PM EDT
3.969
+0.029 (0.73%)
After-hours: May 1, 2026, 4:10 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $408.26 million as of May 1, 2026. Its market cap has increased by 239.16% in one year.
Market Cap
408.26M
Enterprise Value
280.15M
1-Year Change
239.16%
Ranking
Category
Stock Price
$3.94
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $408.26M, an increase of 260.08%. That is a compound annual growth rate of 24.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 421.76M | 29.34% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 465.47M |
| MiMedx Group | 458.33M |
| Entrada Therapeutics | 457.92M |
| Immix Biopharma | 457.49M |
| Eupraxia Pharmaceuticals | 454.46M |
| Candel Therapeutics | 452.67M |
| 4D Molecular Therapeutics | 449.76M |
| Contineum Therapeutics | 449.53M |